Drugs - Drugs Xagena

Drugs

Home Page

Xagena Medicine

Xagena.net

QT prolongation and torsades de pointes linked to Halcion

Premature ejaculation is a frequent male sexual complaint

Overweight and obesity: contraindicated use of Meridia and cardiovascular adverse reactions

Cardiac surgery: Trasylol increases the risk for death compared to the other antifibrinolytic drugs

FDA: Lyrica for treatment of fibromyalgia

Schizophrenia: Clozapine associated with myocarditis

Antidepressants: Mirtazapine linked to blood dyscrasias

EMEA: Acomplia must not be used in patients on antidepressants or with major depression

Hot flushes: EMEA recommends withdrawal of medicinal products containing Veralipride

Asthma: risk of anaphylaxis following administration of Omalizumab

Restricted use of Zelnorm, a drug for irritable bowel syndrome with constipation and chronic idiopathic constipation

NICE: Adalimumab and Rituximab for the treatment of arthritis

EMEA has approved Aclasta as first once-yearly treatment for postmenopausal osteoporosis

Erectile dysfunction drugs linked to potential risk of sudden hearing loss

Antifibrinolytic drugs: FDA has requested marketing suspension of Trasylol

DPP-4 inhibitors: Novartis has improved Galvus risk/benefit profile

FDA has strengthened boxed warnings for erythropoiesis-stimulating agents

Inoperable hepatocellular carcinoma: FDA has approved Nexavar

Avandia: FDA has added boxed warning for cardiovascular risks

Treatment of pain associated with osteoarthritis: Voltaren gel

Antibiotics: Cefepime associated with increased mortality

Hypertension: FDA has approved Bystolic, a beta-blocker

Valproate therapy: risk factors for development of subclinical hypothyroidism

Refractory partial epilepsy: no advantage for Zonisamide

Tumors: recommendations on the use of Zometa

Antioxidants show no clear benefit against cardiovascular events, death in high-risk women

Bizarre sleep related effects linked to Zolpidem

Safety information on Rosiglitazone, a diabetes drug

Diabetes: Avandia linked to risk of myocardial infarction and heart-related deaths

FDA: Neupro patch for treatment of early Parkinson's disease approved

Next Pages 1 [2] 3 4 5 6 7 8 9

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions